$SOPH 4/A SEC Filings

Filed On	Filing
08 Apr 2026	Form 4/A: Van Well Daan, Chief Legal Officer Received 97,536 shares as a grant or award · Granted 142,216 Share Option (Right to Buy)
08 Apr 2026	Form 4/A: Muken Ross, President Received 431,211 shares as a grant or award · Granted 628,743 Share Option (Right to Buy)
08 Apr 2026	Form 4/A: Cardoza George, Chief Financial Officer Received 112,936 shares as a grant or award · Granted 164,671 Share Option (Right to Buy)
08 Apr 2026	Form 4/A: Camblong Jurgi, Director Received 431,211 shares as a grant or award · Granted 628,743 Share Option (Right to Buy)
08 Apr 2026	Form 4/A: Menu Philippe, Chief Medical Officer Received 112,936 shares as a grant or award · Granted 164,671 Share Option (Right to Buy)
08 Apr 2026	Form 4/A: Puylaert Kevin, Chief Sales Officer Received 56,468 shares as a grant or award · Granted 82,335 Share Option (Right to Buy)
08 Apr 2026	Form 4/A: Valente Manuela, Chief People Officer Received 71,869 shares as a grant or award · Granted 104,790 Share Option (Right to Buy)
08 Apr 2026	Form 4/A: Xu Zhenyu, Chief Scientific Officer Received 112,936 shares as a grant or award · Granted 164,671 Share Option (Right to Buy)
08 Apr 2026	Form 4/A: Verma Abhimanyu, Chief Technology Officer Received 82,136 shares as a grant or award · Granted 119,760 Share Option (Right to Buy)

Comments